Cavitation Technologies, Inc. (CVAT)

Every figure this model derived for CVAT, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-03-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PaymentsToAcquirePropertyPlantAndEquipment 2021-06-30
cash 45,000 CashAndCashEquivalentsAtCarryingValue 2026-03-31
current assets 55,000 AssetsCurrent 2026-03-31
current liabilities 383,000 LiabilitiesCurrent 2026-03-31
equity -467,000 StockholdersEquity 2026-03-31
interest expense 4,000 InterestPaidNet 2026-03-31
ocf -709,000 NetCashProvidedByUsedInOperatingActivities 2026-03-31
revenue 11,000 Revenues 2026-03-31
sbc 0 ShareBasedCompensation 2019-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up CVAT on one particular measure came for.

RatioValue
current ratio0.14
current ratio reported0.14
deferred revenue growth-100.0
dilution pct0.6
growth cv3.78
interest cover-297.0
revenue growth-98.71
revenue growth per share-98.71
rpo growth81.34
rule of 40-10898.71
sbc pct revenue0.0

What to be careful about

What this model itself distrusts about CVAT's figures. Written by the derivation as it ran, not added afterwards.